Additional Unani therapy for the patients of rheumatoid arthritis along with modern treatment.
Not Applicable
- Conditions
- Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecifiedHealth Condition 2: M259- Joint disorder, unspecified
- Registration Number
- CTRI/2023/02/049413
- Lead Sponsor
- Department of Ilaj-bit-Tadbeer, Faculty of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients having mild to moderate signs and symptoms of RA (e.g. pain, swelling, stiffness, restricted movements) having score of 6-8 according to the American college of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) 2010, determined on the basis of severity of disease.
2. Patients who have agreed to sign the inform consent form and follow up the protocol
Exclusion Criteria
1.Recent history of Trauma or fracture of bone.
2.Systemic diseases (e.g, Diabetes and Hypertension).
3.Pregnancy and Lactation.
4.Patients having bleeding disorders.
5.Patients on anti-coagulant and anti-platelet therapy.
6.Angina/MI pain.
7.Cardiopulmonary diseases.
8.Patients of RA with extra articular complications.
9.Advance stage of RA.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in subjective parameters VAS ( Visual Analogue Scale ) and <br/ ><br>DAS 28 ( Disease Activity Score ) <br/ ><br>Timepoint: 49 days with 15 days follow up <br/ ><br>
- Secondary Outcome Measures
Name Time Method Improvement in objective parameters (CRP, ESR, Swelling, Stiffness, Restricted movement, <br/ ><br>Tenderness <br/ ><br>Timepoint: 49 days with 15 days follow up <br/ ><br>